4//SEC Filing
Lovejoy Chandra D 4
Accession 0001144204-13-011286
CIK 0001235007other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:16 PM ET
Size
13.7 KB
Accession
0001144204-13-011286
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Lovejoy Chandra D
VP of Regulatory Affairs
Transactions
- Sale
Common Stock
2013-02-25$9.70/sh−1,993$19,332→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2013-02-25−1,993→ 6,609 totalExercise: $3.05Exp: 2017-11-14→ Common Stock (1,993 underlying) - Exercise/Conversion
Common Stock
2013-02-25$2.54/sh+109$277→ 109 total - Sale
Common Stock
2013-02-25$9.70/sh−109$1,057→ 0 total - Exercise/Conversion
Common Stock
2013-02-25$3.05/sh+1,993$6,079→ 1,993 total - Exercise/Conversion
Stock Option (right to buy)
2013-02-25−109→ 655 totalExercise: $2.54Exp: 2019-08-13→ Common Stock (109 underlying)
Footnotes (3)
- [F1]The shares were sold pursuant to a written plan as specified in Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Shares subject to vest monthly over a period of 48 months beginning on August 31, 2009.
- [F3]Shares subject to vest 50% on November 14, 2009 and monthly over a period of 24 months beginning on November 30, 2009.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeother
Related Parties
1- filerCIK 0001509420
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:16 PM ET
- Size
- 13.7 KB